# Contineum Therapeutics

Type: Company (CTNM)

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/contineum-therapeutics
Canonical HTML page: https://getfinancebrief.com/entity/contineum-therapeutics

## Recent coverage (1 stories)

### Hold Upgrades for CTNM and ENVB: $20.25 Target vs $1.43 Microcap
2026-08-24 11:32:31 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

A Sunday analyst action shifted two healthcare microcaps from Sell to Hold. CTNM carries a $646.69M valuation and a $20.25 consensus target, while ENVB trades at $1.43 with a $6.41M market cap and negative P/E.
Full story: https://getfinancebrief.com/story/wall-street-zen-ctnm-envb-hold-upgrades-finance

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.